about
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effectsCannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patientsCannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disordersPharmacological treatment of anxiety disorders: current treatments and future directionsInverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life.Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research.Anti-aversive effects of cannabidiol on innate fear-induced behaviors evoked by an ethological model of panic attacks based on a prey vs the wild snake Epicrates cenchria crassus confrontation paradigm.Pharmacological interventions in the treatment of the acute effects of cannabis: a systematic review of literatureEven High Doses of Oral Cannabidol Do Not Cause THC-Like Effects in Humans: Comment on Merrick et al. Cannabis and Cannabinoid Research 2016;1(1):102-112; DOI: 10.1089/can.2015.0004.Direct intra-accumbal infusion of a beta-adrenergic receptor antagonist abolishes WIN 55,212-2-induced aversion.Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol.Marijuana, feijoada and the debate on drug legalizationNo Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor
P2860
Q24606148-CCE35605-B02F-4FE5-A86F-2BD12A769235Q24611774-53C9034A-335A-4F50-8D22-609E82DD1CC1Q26823267-EBB1D0EC-B443-40C2-B64D-2203279BDBE3Q26851461-38C6055D-BE91-4B81-AED1-70A9C3422BCDQ33658933-99933662-995F-4156-874E-3E482A1ACAD8Q33819365-52123AD1-4437-42BF-B2D1-70BDCCA99477Q34028554-6786075E-B8B0-41EB-A2CF-4F4BAAB12861Q34635342-F73C0C5D-D84B-4588-98CD-9CCBF7A8D441Q38598503-F5912416-4E26-4720-8BC0-71A2C7F5D9F7Q39658389-AFC2159D-AC0D-487E-89ED-AF0AC2EC28EFQ41236873-94EDF669-82FA-44D2-B23B-3C93EB806844Q41613666-626C7476-7FFF-4268-91AC-9908BB721BE8Q55120181-79FEB5EC-40FB-4B46-B084-B58006CDCBB4Q58732614-76B9C9DD-414D-475B-BD49-705D005EFE93
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
[Therapeutical use of the cannabinoids in psychiatry].
@en
[Therapeutical use of the cannabinoids in psychiatry].
@nl
type
label
[Therapeutical use of the cannabinoids in psychiatry].
@en
[Therapeutical use of the cannabinoids in psychiatry].
@nl
prefLabel
[Therapeutical use of the cannabinoids in psychiatry].
@en
[Therapeutical use of the cannabinoids in psychiatry].
@nl
P1476
[Therapeutical use of the cannabinoids in psychiatry].
@en
P2093
Jaime E C Hallak
José Alexandre S Crippa
P304
P407
P478
32 Suppl 1
P577
2010-05-01T00:00:00Z